Apomorphine Hydrochloride is an agonist of dopamine D2 used for the treatment of Parkinson's disease. Protein levels of two types of serine-phosphorylated insulin receptor substrate-1 (IRS-1), pS616 and pS636/639, significantly decreased following Apomorphine treatment in the 13-month-old 3xTg-AD mice brain, suggesting improved brain insulin resistance.

314-19-2

C17H18ClNO2

303.78

KW-6500;APL130277;Apomorphine HCl;APL 130277;APL-130277;Apomorphine Hydrochloride

DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years